Possibly, the antigen presentation by MHCII on tumor cells and the T-cell receptor (TCR) repertoire of CD4+ T cells are determining factors for such interactions, as suggested from our tetramer analysis (although limited) that showed almost no tetramer staining for effector CD4+ T cells in the saline control group. This evidence concerns the gene CD4 and neoplasm.